Chemical spill at Hetero pharma unit in Sangareddy injures three workers; Probe underway

Sangareddy: The incident happened when the employes were filling the reactor with chemicals. However, the management of Hetero kept the incident secret.

Three employees of Hetero Pharmaceuticals Limited were injured as chemicals spilled out of a reactor at its Khaji pally unit on Thursday late night.

The incident happened when the employees were filling the reactor with chemicals. However, the management of Hetero kept the incident secret.

But, the news broke out when the night shift workers walked out of the company on Friday morning. The injured were rushed to a corporate hospital in Hyderabad for treatment.

Two of three injured were casual workers at the company and another was a permanent employee. The Jinnaram police registered a case. The probe is on.

Related Posts

  • Pharma
  • April 25, 2025
  • 24 views
250% rally in one year! Multibagger pharma stock jumps despite stock market crash

Stock Marke:  With 250% rally in one year the Multibagger pharma stock gained further on the BSE on Friday, during the intraday trades despite stock market crash. The Sudarshan Pharma…

  • Pharma
  • April 25, 2025
  • 42 views
Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue

Drugmaker Laurus Labs reported consolidated net profit for the March quarter surged to ₹233.87 crore from ₹75.32 crore a year earlier on a 19% increase in the revenue. Revenue from…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

250% rally in one year! Multibagger pharma stock jumps despite stock market crash

250% rally in one year! Multibagger pharma stock jumps despite stock market crash

Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue

Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue

Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively

Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively

Novo Nordisk to phase out country’s largest insulin brand

Novo Nordisk to phase out country’s largest insulin brand